Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

XSSC:603392 Stock Report

Market Cap: CN¥91.1b

Beijing Wantai Biological Pharmacy Enterprise Balance Sheet Health

Financial Health criteria checks 5/6

Beijing Wantai Biological Pharmacy Enterprise has a total shareholder equity of CN¥12.6B and total debt of CN¥267.0M, which brings its debt-to-equity ratio to 2.1%. Its total assets and total liabilities are CN¥14.7B and CN¥2.1B respectively.

Key information

2.1%

Debt to equity ratio

CN¥267.03m

Debt

Interest coverage ration/a
CashCN¥5.50b
EquityCN¥12.61b
Total liabilitiesCN¥2.13b
Total assetsCN¥14.74b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 603392's short term assets (CN¥9.0B) exceed its short term liabilities (CN¥1.9B).

Long Term Liabilities: 603392's short term assets (CN¥9.0B) exceed its long term liabilities (CN¥180.9M).


Debt to Equity History and Analysis

Debt Level: 603392 has more cash than its total debt.

Reducing Debt: 603392 had negative shareholder equity 5 years ago, but is now positive and has therefore improved.

Debt Coverage: 603392's debt is well covered by operating cash flow (316.3%).

Interest Coverage: Insufficient data to determine if 603392's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies